Want to know where medicine will be in 20 years?
Follow the money.
Specifically, where the NIH puts its dollars.
Much of what’s now standard care began as federally funded research decades ago. Many of today’s billion-dollar therapies began as taxpayer-funded studies.
But as of now, that same research investment is being questioned and cut.
In this episode, we unpack the real ROI of public science, why pharma’s biggest wins often trace back to NIH discoveries, and what happens if that chain breaks with Dr. Mahmood Razavi.
Go to the Life of Flow podcast channel and watch the full episode #91 with Dr. Mahmood Razavi.
